Pineridge Advisors LLC Procaps Group, S.A. Transaction History
Pineridge Advisors LLC
- $264 Billion
- Q3 2024
A detailed history of Pineridge Advisors LLC transactions in Procaps Group, S.A. stock. As of the latest transaction made, Pineridge Advisors LLC holds 250 shares of PROC stock, worth $570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$570
Previous $628,000
12.42%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PROC
# of Institutions
6Shares Held
53.3KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA28.9KShares$65,9780.0% of portfolio
-
United Maritime Capital LLC New York, NY14KShares$31,9190.64% of portfolio
-
Activest Wealth Management10KShares$22,7990.01% of portfolio
-
Morgan Stanley New York, NY100Shares$2270.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Procaps Group, S.A.
- Ticker PROC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 112,824,000
- Market Cap $257M
- Description
- Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...